Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
![GettyImages-1294339667-scientists-protective-gear-tablet-teamwork]( "Nitrosamine Risk Management: Your Questions Answered")
Nitrosamine Risk Management: Your Questions AnsweredNavigate nitrosamine impurities with early risk assessments, trace-level analytical testing, and careful excipient evaluation. Learn strategies to strengthen compliance and optimize testing programs.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Choosing The Right Solid Form")
Choosing The Right Solid FormMastering polymorph screening helps prevent costly reformulation delays. Explore phase-appropriate strategies, experimental methods, and structural informatics for crystal form selection.
-
![Blood diagnostics, laboratory testing, disease biomarkers, medical technology-GettyImages-2218591456]( "From Biomarker Data To Proof Of Mechanism")
From Biomarker Data To Proof Of MechanismBiomarker values support mechanism only when the decision, analytical plan, and validation are designed as one chain, with expected direction of change and baseline noise defined before sampling.
-
![trialkit-api-GettyImages-2223712653]( "Difficult-To-Purify And Difficult-To-Filter Small Molecules")
Difficult-To-Purify And Difficult-To-Filter Small MoleculesPoor filterability and stubborn impurities often trace back to the same molecular features, which changes how development teams approach scale-up for larger, structurally complex small molecules.
-
![scientists working in laboratory-GettyImages-525440711]( "Choosing The Right CDMO For Substance Development And Manufacturing")
Choosing The Right CDMO For Substance Development And ManufacturingControlled substance programs demand licensing, closed-system custody, and inspection history well beyond GMP. Sponsors weighing partners must test technical depth against compliance infrastructure.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
![partnership or agreement in the pharmaceutical industry-GettyImages-2173667078]( "From Early Development To Commercial Launch: An End-To-End Partnership")
From Early Development To Commercial Launch: An End-To-End PartnershipBringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.
-
![pharmacology, chemistry, micropipette, biotechnology, Liquid Chromatography-GettyImages-1494345439]( "Selecting The Right Chromatography Strategy")
Selecting The Right Chromatography StrategyDifficult small molecule purifications rarely yield to one technique. Modeling, fraction mapping, and preparative HPLC each solve a different problem, and the right choice depends on the molecule.
-
![GettyImages-1052204504-crystallization]( "Optimizing Particle Properties For Difficult Small Molecules")
Optimizing Particle Properties For Difficult Small MoleculesCrystal morphology and unexpected solid-state intermediates often decide whether a difficult small molecule filters, dries, and scales. Thermodynamic stability may not be the right target.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Turning A \"Brick Dust\" Compound Into A Clinically Viable Oral Formulation")
Turning A "Brick Dust" Compound Into A Clinically Viable Oral FormulationAdvanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
-
![Drug R-D_GettyImages-1483266787]( "Creating A New Dosage Form From An Approved Drug For A New Rare Disease")
Creating A New Dosage Form From An Approved Drug For A New Rare DiseaseAdvancing approved drugs into new indications requires smart formulation, strong quality controls, and regulatory expertise to overcome challenges and accelerate patient access.
FORMULATION DEVELOPMENT PRODUCTS & SERVICES
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
Our solutions have been specified in the testing process for the top two GLP-1 manufacturers
Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
Leica M125 C Encoded Stereo Microscopes
Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
- Coded microscopes consistently deliver calibrated and comparable images
- Reproduce images in moments with the Leica “Store and Recall” function
- Fully apochromatic corrected zoom optics deliver high quality images
- Customize the microscope system to your task with the exclusive range of accessories
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.
Leica DM3000
Enhance Laboratory Workflow
The Leica DM3000 microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
FORMULATION DEVELOPMENT SOLUTIONS
- Automated Cell Imaging System
- CDO Services: Agile. Flexible. Focused On You.
- Arc HPLC
- Gibco Efficient-Pro Medium And Feeds Evaluation Guide
- Our Science-Forward Approach To API Development, Manufacturing
- Keep A Close Eye On Quality With Excipients For Drug Formulation
- Rapid Sterility Testing: Actionable Results In Less Than 5 Hours
- Predict And Assign Fragment Ions
- High-Quality Filter Housings For Sanitary Applications
- Adare Pharma Solutions (APS) Orbis Overview
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence
- Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina
- Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand
- ROSS Portable High Shear Mixing System
- Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request
- Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus
- Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 2027
- LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services
- MVIC And Upperton Pharma Solutions Announce Strategic Collaboration
- All-In-One Solution For Continuous Microbial Monitoring Without Production Interruptions